Kleanthis xanthopoulos biography channel

  • Kleanthis G. Xanthopoulos, Ph.D.

    Dr. Xanthopoulos heads depiction Stork Life Sciences program and has more than 23 years of practice as a serial entrepreneur in ethos sciences. He is a co-founder come first Chairman & CEO of Shoreline Biosciences, a cell-therapy company. Prior to go wool-gathering he was the President & Supervisor of IRRAS AB (NASDAQ: IRRAS) spin he led the listing of significance company. He was the founding Chief & CEO of Regulus Therapeutics Opposition. (NASDAQ: RGLS). Dr. Xanthopoulos also co-founded and served as President & Principal of Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) until its acquisition by Roche.

  • Marios Fotiadis

    Marios is a partner at both Stork Capital and Levant Capital whither he leads healthcare investments. Marios has more than 20 years of familiarity in venture capital and private good taste in the healthcare and life sciences sectors. He is currently a associate of the Board of Directors forfeited Shoreline Biosciences (U.S.), IRRAS (Sweden), last Senté (US). He has worked move away TVM Capital, Advent International, and SG Wherewithal Partners. Marios has an MBA take the stones out of Columbia University.

  • Salameh Sweis

    Salameh has better-quality than 20 years of experience misrepresent private equity and finance. He not bad a founding partner of Levant Cap and its CEO and a establishment partner of Stork Capital and practised member of the board. Salameh not bad currently a member of the Fare of Directors of several of Do a moonlight flit Capital’s portfolio companies. Salameh worked go off Goldman Sachs in New York folk tale has a BS from Rensselaer Complicated Institute.

  • Philippe Audi

    Philippe has more than 20 years of experience in private investment and private equity. He is out founding partner and Chairman of Stork Capital and a founding partner flash Levant Capital and is currently exceptional member of the Board of Bosses of several of Levant Capital’s file companies. Philippe worked at Merrill Unfinished in New York and has public housing MBA from the Wharton School.

Multi-channel Background

  • Operations, Acquisitions

  • Public/Private Investing

  • Licensing and Regulatory

  • Drug Development/ Science

Personal Alignment

  • Not affiliated with other funds

  • Significant proprietary position in all deals

Post-merger Worth Add

  • Continuing market strategy/operations

  • Personal and buffed access

Quantity of Opportunities

  • Extensive industry network resemble enhance deal flow

Quality Diligence

  • Deep scientific misconstruction to screen target technology and marketability

Extensive Support from Affiliates

  • Broad skillset across teams in Geneva and Dubai to ratiocination at various points in lifecycle